MORRIS GABRIEL S (Chief Financial Officer) received a stock award from IMMIX BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 5/20/2024ACC: 0001493152-24-020776
DirectorOfficer· Chief Financial Officer
Since Dec 2021
+242.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
242.50K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+194.22K
Price / share
—
Trade value
—
% of position
226.3%
5/20/2024
85.82K→280.03K
Common Stock
Indirect
Shares
+24.14K
Price / share
—
Trade value
—
% of position
9.8%
5/20/2024
246.70K→270.84K
Common Stock
Indirect
Shares
+24.14K
Price / share
—
Trade value
—
% of position
New position
5/20/2024
0.00→24.14K
Total
Net shares
+242.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/20/2024 | A · Award | +194.22K | — | — | 226.3% | 85.82K | 280.03K |
| Common Stock Indirect | 5/20/2024 | A · Award | +24.14K | — | — | 9.8% | 246.70K | 270.84K |
| Common Stock Indirect | 5/20/2024 | A · Award | +24.14K | — | — | New position | 0.00 | 24.14K |
| Total | +242.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported